Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-24 @ 4:35 PM
NCT ID:
NCT06021366
Eligibility Criteria:
Inclusion Criteria:
• Patients aged ≥50 years with a nAMD diagnosis, who received ≥1 brolucizumab prescription regardless of prior anti-VEGF treatment, and had a minimum of 12-month follow-up from index date.
Exclusion Criteria:
* Patients without a record of prescription of any drug in the six months before the index date (pre-index period).
* Patients with evidence of bilateral treatment with brolucizumab.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT06021366
Study Brief:
Protocol Section:
NCT06021366